NOVO-B:CPH
Novo Nordisk A/S
253,40 DKK
arrow_downward
-1,27%(-3,25) 1 Д
14. окт, 13:22:58 GMT+2 · DKK
search
Сви симболи
| Симбол | Цена | Промена | % промене |
|---|
insights_autoГенеришу се најзначајнији увиди за NOVO-B...
Отвори
253,25 DKK
Високо
254,95 DKK
Ниско
252,30 DKK
Трж. капитализација
869,23 млрд.
Прос. количина
5,19 мил.
Количина
771,97 хиљ.
Највиша у 52 недеље
409,95 DKK
Најнижа у 52 недеље
224,25 DKK
Акцијски капитал
3,39 млрд.
Бр. запослених
67 хиљ.
Отвори
253,25 DKK
Високо
254,95 DKK
Ниско
252,30 DKK
Трж. капитализација
869,23 млрд.
Прос. количина
5,19 мил.
Количина
771,97 хиљ.
Највиша у 52 недеље
409,95 DKK
Најнижа у 52 недеље
224,25 DKK
Акцијски капитал
3,39 млрд.
Бр. запослених
67 хиљ.
Вести
Из веб-извора и од партнера за вести
ad-hoc-news.de
·
пре 9 минута
BMO cuts target for Novo Nordisk stock to USD 40.00
ad-hoc-news.de
·
пре 5 сати
Novo Nordisk stock pre-market at EUR 33.91
Traders Union
·
пре 6 сати
India emerges as a key hub in pharmaceutical companies’ anti-obesity business and research strategy
The Motley Fool
·
пре 13 сати
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Профил
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Novo Nordisk A/S – основни подаци
Главни извршни директорМазијар Мајк Дустдар
Запослени66,7 хиљ.
Основано1923
СедиштеBagsværd, Велики Копенхаген, Данска
Сектор-
Веб-сајтnovonordisk.com